A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death
- 11 January 2011
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 42 (3) , 252-264
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The neurobiology of amyotrophic lateral sclerosisEuropean Journal of Neuroscience, 2010
- A pilot open label, single dose trial of fenobam in adults with fragile X syndromeJournal of Medical Genetics, 2009
- Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis–cerebrospinal fluid toxicity in vitroNeuroscience, 2006
- A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosisBrain Research Reviews, 2004
- Glial Proliferation and Metabotropic Glutamate Receptor Expression in Amyotrophic Lateral SclerosisJournal of Neuropathology & Experimental Neurology, 2004
- Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteinsEuropean Journal of Neuroscience, 2003
- Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytesNeuroscience, 2001
- Elevated Cortical Extracellular Fluid Glutamate in Transgenic Mice Expressing Human Mutant (G93A) Cu/Zn Superoxide DismutaseJournal of Neurochemistry, 2000
- Differential Expression of Group I Metabotropic Glutamate Receptors in Rat Spinal Cord Somatic and Autonomic Motoneurons: Possible Implications for the Pathogenesis of Amyotrophic Lateral SclerosisNeurobiology of Disease, 1999
- The Neuroprotective Activity of Group-II Metabotropic Glutamate Receptors Requires New Protein Synthesis and Involves a Glial–Neuronal SignalingJournal of Neuroscience, 1997